Esperante Ventures

Portfolio

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Esperante Ventures' primary sector focus for investments?

Esperante Ventures primarily focuses on the Health Tech & Life Sciences sector, with all three of its recorded investment rounds and both of its portfolio companies falling within this area.

Can you name some notable companies in Esperante Ventures' portfolio?

Esperante Ventures' portfolio includes Silexion Therapeutics and Atox Bio, both operating in the Health Tech & Life Sciences sector.

What is the typical investment amount range for Esperante Ventures?

Esperante Ventures' investment amounts have ranged from $2.35 million to $10 million per round.

When did Esperante Ventures make its first recorded investment?

Esperante Ventures made its first recorded investment in December 2011.

Has Esperante Ventures acted as a lead investor in its portfolio companies?

Yes, Esperante Ventures has acted as a lead investor in at least two rounds: a $3.25 million investment in Atox Bio in December 2011 and a $2.35 million investment in Silexion Therapeutics in October 2015.

What was Esperante Ventures' most recent investment activity?

Esperante Ventures' most recent recorded investment was in Silexion Therapeutics in October 2015, where they invested $2.35 million as a lead investor.

How many new portfolio companies did Esperante Ventures add in 2014?

Esperante Ventures added one new portfolio company in April 2014, which was Silexion Therapeutics.

What is the total number of investment rounds Esperante Ventures has participated in, according to startupim data?

Esperante Ventures has participated in three recorded investment rounds, with activity in 2011, 2014, and 2015.